Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
Prensa méd. argent ; 105(10): 667-677, oct 2019. fig, graf
Artículo en Español | BINACIS, LILACS | ID: biblio-1025940

RESUMEN

The authors present a clinical and farmacological evaluation of the effect and safety of N-acetylcysteine in chronic obstructive diseases. The N-actylcysteine (NAC) is a sulphorated amino acid employed as an mucolytic agent. The efficacy and tolerability of oral NAC as compared with other agents was determined, in the mucolytic treatment on mucus hypersecretion and in the management of respiratory tract fluids and sputums from cigarette smokers, and also as a bronchial mucus fluidifying agent. A sistematic review and analysis of the effect of NAC and its effectiveness. In the treatment of acute respiratory disorders in children was determined


Asunto(s)
Humanos , Acetilcisteína/uso terapéutico , Acetilcisteína/farmacología , Bromhexina/farmacología , Mucosa Respiratoria/fisiopatología , Moco/efectos de los fármacos
2.
Indian J Chest Dis Allied Sci ; 1989 Jan-Mar; 31(1): 33-6
Artículo en Inglés | IMSEAR | ID: sea-30091

RESUMEN

Nasal mucus clearance (NMC) was studied in seventy patients with chronic maxillary sinusitis. Forty-five patients were treated with oral administration of bromhexine tablets along with oral antibiotics and nasal decongestants. Twenty-five patients received the same treatment but without bromhexine to evaluate the results. NMC was also studied in hundred healthy controls.


Asunto(s)
Bromhexina/farmacología , Enfermedad Crónica , Femenino , Humanos , Masculino , Sinusitis Maxilar/tratamiento farmacológico , Moco/metabolismo , Mucosa Nasal/efectos de los fármacos
3.
Arq. bras. oftalmol ; 50(6): 253-7, 1987. ilus, tab
Artículo en Portugués | LILACS | ID: lil-48343

RESUMEN

Foram estados, em 21 pacientes portadoras de Síndrome de Sjögren primária ou secundária, a influência da bromohexine sobre os níveis de lisozima da secreçäo lacrimal, teste de rosa bengala e sintomas oculares. Realizamos estudo cego com administraçäo de placebo (um comprimido por dia) e bromohexine (um comprimido de 48 mg por dia), durante 2 períodos consecutivos de 3 semanas (21 dias), com avaliaçöes do nível de lisozima lacrimal, sintomas oculares e teste de rosa bengala no dia antecedente ao ínicio do tratamento e após o uso de placebo (22§) e de bromohexine (44§ dia). Näo houve influência estatisticamente significante da bromohexine sobre os parâmetros analisados


Asunto(s)
Humanos , Bromhexina/farmacología , Lágrimas , Muramidasa/análisis , Síndrome de Sjögren/tratamiento farmacológico , Lágrimas
4.
Pesqui. méd. (Porto Alegre) ; 19(2): 120-4, 1985.
Artículo en Portugués | LILACS | ID: lil-29211

RESUMEN

Faz-se uma revisäo sobre mucolíticos, principalmente, sobre a Bromexine. Discute-se suas propriedades farmacológicas e seu perfil de prescriçäo em nosso meio


Asunto(s)
Bromhexina/uso terapéutico , Enfermedades Bronquiales/tratamiento farmacológico , Bromhexina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA